Search Results - "CHIN, DANIEL P"

Refine Results
  1. 1
  2. 2

    National Survey of Drug-Resistant Tuberculosis in China by Zhao, Yanlin, Xu, Shaofa, Wang, Lixia, Chin, Daniel P, Wang, Shengfen, Jiang, Guanglu, Xia, Hui, Zhou, Yang, Li, Qiang, Ou, Xichao, Pang, Yu, Song, Yuanyuan, Zhao, Bing, Zhang, Hongtao, He, Guangxue, Guo, Jing, Wang, Yu

    Published in The New England journal of medicine (07-06-2012)
    “…This survey showed that about 6% of new cases and 26% of previously treated cases of TB in China were multidrug-resistant (MDR); about 8% of MDR cases were…”
    Get full text
    Journal Article
  3. 3

    Emergence and control of infectious diseases in China by Wang, Longde, Prof, Wang, Yu, Prof, Jin, Shuigao, Prof, Wu, Zunyou, Prof, Chin, Daniel P, MD, Koplan, Jeffrey P, Prof, Wilson, Mary Elizabeth, MD

    Published in The Lancet (British edition) (01-11-2008)
    “…Summary Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Progress in tuberculosis control and the evolving public-health system in China by Wang, Longde, Prof, Liu, Jianjun, MD, Chin, Daniel P, Dr

    Published in The Lancet (British edition) (24-02-2007)
    “…Summary China has the world's second largest tuberculosis epidemic, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis…”
    Get full text
    Journal Article
  6. 6

    Tuberculosis control in China: use of modelling to develop targets and policies by Lin, Hsien-Ho, Wang, Lixia, Zhang, Hui, Ruan, Yunzhou, Chin, Daniel P, Dye, Christopher

    Published in Bulletin of the World Health Organization (01-11-2015)
    “…It is unclear if current programmes in China can achieve the post-2015 global targets for tuberculosis - 50% reduction in incidence and a 75% reduction in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in China by Ou, Xichao, Li, Qiang, Xia, Hui, Pang, Yu, Wang, Shengfen, Zhao, Bing, Song, Yuanyuan, Zhou, Yang, Zheng, Yang, Zhang, Zhijian, Zhang, Zhiying, Li, Junchen, Dong, Haiyan, Zhang, Jack, Kam, Kai Man, Chi, Junying, Huan, Shitong, Chin, Daniel P, Zhao, Yanlin

    Published in PloS one (01-05-2014)
    “…Early and effective detection of Mycobacterium tuberculosis (MTB), particularly in smear-negative tuberculosis (TB), is a priority for global TB control…”
    Get full text
    Journal Article
  9. 9

    The impact of the COVID-19 epidemic on tuberculosis control in China by Fei, Huang, Yinyin, Xia, Hui, Chen, Ni, Wang, Xin, Du, Wei, Chen, Tao, Li, Shitong, Huan, Miaomiao, Sun, Mingting, Chen, Keshavjee, Salmaan, Yanlin, Zhao, Chin, Daniel P., Jianjun, Liu

    “…In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine…”
    Get full text
    Journal Article
  10. 10

    Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China by Huang, Fei, van den Hof, Susan, Qu, Yan, Li, You, Zhang, Hui, Wang, Lixia, Sun, Miaomiao, Lu, Wei, Hou, Shuangyi, Zhang, Tianhua, Huan, Shitong, Chin, Daniel P, Cobelens, Frank

    Published in Emerging infectious diseases (01-07-2019)
    “…The increase in drug-resistant tuberculosis in China calls for scaling up rapid diagnosis. We evaluated introduction of rapid resistance testing by line-probe…”
    Get full text
    Journal Article
  11. 11

    The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis by Arinaminpathy, Nimalan, Gomez, Gabriela B, Sachdeva, Kuldeep S, Rao, Raghuram, Parmar, Malik, Nair, Sreenivas A, Rade, Kiran, Kumta, Sameer, Hermann, David, Hanson, Christy, Chin, Daniel P, Dewan, Puneet

    Published in PloS one (27-03-2020)
    “…There is increasing interest in future, highly-potent 'pan-TB' regimens against tuberculosis (TB), that may be equally effective in both drug-susceptible and…”
    Get full text
    Journal Article
  12. 12

    Multicenter Evaluation of Genechip for Detection of Multidrug-Resistant Mycobacterium tuberculosis by Pang, Yu, Xia, Hui, Zhang, Zhiying, Li, Junchen, Dong, Yi, Li, Qiang, Ou, Xichao, Song, Yuanyuan, Wang, Yufeng, O'Brien, Richard, Kam, Kai Man, Chi, Junying, Huan, Shitong, Chin, Daniel P, Zhao, Yanlin

    Published in Journal of Clinical Microbiology (01-06-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13

    Access to and affordability of healthcare for TB patients in China: issues and challenges by Tang, Shenglan, Wang, Lixia, Wang, Hong, Chin, Daniel P

    Published in Infectious diseases of poverty (29-01-2016)
    “…This paper introduces the background, aim and objectives of the project entitled "China-the Gates Foundation Collaboration on TB Control in China" that has…”
    Get full text
    Journal Article
  14. 14

    Superspreading SARS events, Beijing, 2003 by Shen, Zhuang, Ning, Fang, Zhou, Weigong, He, Xiong, Lin, Changying, Chin, Daniel P, Zhu, Zonghan, Schuchat, Anne

    Published in Emerging infectious diseases (01-02-2004)
    “…Superspreading events were pivotal in the global spread of severe acute respiratory syndrome (SARS). We investigated superspreading in one transmission chain…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Multicenter Evaluation of the Molecular Line Probe Assay for Multidrug Resistant Mycobacterium Tuberculosis Detection in China by Li, Qiang, Dong, Hai Yan, Pang, Yu, Xia, Hui, Ou, Xi Chao, Zhang, Zhi Ying, Li, Jun Chen, Zhang, Jian Kang, Huan, Shi Tong, Chin, Daniel P, Kam, Kai Man, Zhao, Yan Lin

    Published in Biomedical and environmental sciences (01-06-2015)
    “…In order to evaluate the performance of a molecular Hain line probe assay (Hain LPA) for rapid detection of rifampicin and isoniazid resistance of…”
    Get more information
    Journal Article
  18. 18

    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries by Hanson, Christy, Osberg, Mike, Brown, Jessie, Durham, George, Chin, Daniel P.

    Published in The Journal of infectious diseases (06-11-2017)
    “…Abstract Background Despite significant progress in diagnosis and treatment of tuberculosis over the past 2 decades, millions of patients with tuberculosis go…”
    Get full text
    Journal Article
  19. 19

    Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China by Pang, Yu, Li, Qiang, Ou, Xichao, Sohn, Hojoon, Zhang, Zhiying, Li, Junchen, Xia, Hui, Kam, Kai Man, O'Brien, Richard J, Chi, Junying, Huan, Shitong, Chin, Daniel P, Zhao, Yan-lin

    Published in PloS one (23-07-2013)
    “…Genechip (CapitalBio, Beijing, China) is a system for diagnosing resistance to rifampin and isoniazid, which shows high efficiency in detecting drug-resistant…”
    Get full text
    Journal Article
  20. 20

    A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China by Ou, Xichao, Xia, Hui, Li, Qiang, Pang, Yu, Wang, Shengfen, Zhao, Bing, Song, Yuanyuan, Zhou, Yang, Zheng, Yang, Zhang, Zhijian, Zhang, Zhiying, Li, Junchen, Dong, Haiyan, Chi, Junying, Zhang, Jack, Kam, Kai Man, Huan, Shitong, Jun, Yue, Chin, Daniel P, Zhao, Yanlin

    “…Highlights • A multicenter feasibility study of Xpert MTB/RIF assay was conducted in China. • A total of 2,142 non MDR-TB suspects and 312 MDR-TB suspects were…”
    Get full text
    Journal Article